Results 31 to 40 of about 59 (57)
NorUrsodeoxycholic acid (norUDCA) is a side‐chain‐shortened derivative of ursodeoxycholic acid (UDCA) with specific pharmacological properties, including cholehepatic shunting, making it a promising candidate for a range of cholestatic and metabolic liver diseases.
Veerendra Kumar Panuganti +6 more
wiley +1 more source
Clinical Outcomes in Patients With CLL Treated With BTKi at a Large US Cancer Center
Patients with chronic lymphocytic leukemia (CLL) treated with covalent Bruton’s tyrosine kinase inhibitors (BTKi) eventually discontinue treatment, but data on outcomes post‐BTKi treatment discontinuation are limited. In this single‐institution, retrospective chart review of 104 adult patients with CLL treated with a covalent BTKi between July 2011 and
Kevin H. Lin +12 more
wiley +1 more source
In this inverse probability treatment weighting analysis, we compared the outcomes of durvalumab after chemoradiotherapy (CRT‐D group) and chemoradiotherapy alone (CRT group) in patients with locoregional recurrence of non–small‐cell lung cancer (NSCLC) after complete resection.
Megumi Furuta +19 more
wiley +1 more source
A statistical approach to law school citation rankings
Abstract Citation rankings have emerged as a popular approach to ranking the scholarly impact of law faculties. This paper develops a statistical approach for inferring faculty quality from citation counts and determining when differences among law schools are significant.
Joshua Fischman
wiley +1 more source
Policy approaches to stimulate exports: The case of Georgia
Abstract This report examines exporters’ challenges and possible solutions for public intervention to promote foreign trade. Based on fieldwork conducted in Georgia, we explore which policy approaches can help to stimulate Georgian exports further. Our outcomes show that exporters face substantial barriers such as navigating complex trade regulations ...
Andreas Klasen +3 more
wiley +1 more source
Abstract Objective To describe treatment patterns and direct healthcare costs over 3 years following initiation of standard of care acute and preventive migraine medications in patients with migraine in the United States. Background There are limited data on long‐term (>1 year) migraine treatments patterns and associated outcomes.
Shivang Joshi +8 more
wiley +1 more source
Plenary Abstracts Session & Oral Presentations
HemaSphere, Volume 10, Issue S1, June 2026.
wiley +1 more source
86th Annual Meeting of the Meteoritical Society (2024)
Meteoritics &Planetary Science, Volume 59, Issue S1, Page A1-A468, August 2024.
wiley +1 more source
Some of the next articles are maybe not open access.

